To dissect the influence of the tumor on the dynamics of CD431B11+CD8+ and CD431B11+CD4+ T cells, we treated non-tumor-bearing mice (mock challenged) with anti-OX40/CpG, anti-PD-L1, or PDOX. This evidence concerns the gene TNFRSF4 and neoplasm.